Iris Spiliopoulou

4.0k total citations
136 papers, 2.7k citations indexed

About

Iris Spiliopoulou is a scholar working on Infectious Diseases, Molecular Biology and Clinical Biochemistry. According to data from OpenAlex, Iris Spiliopoulou has authored 136 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 81 papers in Infectious Diseases, 54 papers in Molecular Biology and 44 papers in Clinical Biochemistry. Recurrent topics in Iris Spiliopoulou's work include Antimicrobial Resistance in Staphylococcus (69 papers), Bacterial biofilms and quorum sensing (48 papers) and Bacterial Identification and Susceptibility Testing (44 papers). Iris Spiliopoulou is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (69 papers), Bacterial biofilms and quorum sensing (48 papers) and Bacterial Identification and Susceptibility Testing (44 papers). Iris Spiliopoulou collaborates with scholars based in Greece, Switzerland and France. Iris Spiliopoulou's co-authors include Efthimia Petinaki, Antigoni Foka, Evangelos D. Anastassiou, Markos Marangos, Matthaios Papadimitriou‐Olivgeris, G. Dimitracopoulos, Fevronia Kolonitsiou, Christina Bartzavali, Chrisoula D. Scopa and Constantine Vagianos and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Spine.

In The Last Decade

Iris Spiliopoulou

135 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Iris Spiliopoulou Greece 31 1.3k 930 696 662 490 136 2.7k
Peter K. Linden United States 25 1.4k 1.1× 462 0.5× 932 1.3× 869 1.3× 615 1.3× 34 2.8k
Robert H.K. Eng United States 33 1.5k 1.1× 510 0.5× 467 0.7× 1.5k 2.2× 608 1.2× 116 3.4k
Gülşen Hasçelik Türkiye 27 608 0.5× 413 0.4× 187 0.3× 758 1.1× 355 0.7× 165 2.6k
Sofia Maraki Greece 31 828 0.6× 445 0.5× 204 0.3× 1.2k 1.8× 805 1.6× 161 2.9k
Mehdi Goudarzi Iran 31 1.3k 1.0× 1.2k 1.3× 444 0.6× 559 0.8× 615 1.3× 219 3.1k
Reza Ghotaslou Iran 30 412 0.3× 904 1.0× 294 0.4× 594 0.9× 979 2.0× 145 3.1k
Rama Chaudhry India 28 941 0.7× 714 0.8× 173 0.2× 870 1.3× 266 0.5× 188 3.3k
Michael D. Parkins Canada 34 789 0.6× 1.8k 1.9× 364 0.5× 959 1.4× 857 1.7× 127 4.2k
Jagdish Chander India 32 1.2k 0.9× 277 0.3× 194 0.3× 867 1.3× 341 0.7× 208 3.4k
Joerg Steinmann Germany 30 1.4k 1.1× 588 0.6× 168 0.2× 1.1k 1.6× 257 0.5× 138 3.1k

Countries citing papers authored by Iris Spiliopoulou

Since Specialization
Citations

This map shows the geographic impact of Iris Spiliopoulou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iris Spiliopoulou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iris Spiliopoulou more than expected).

Fields of papers citing papers by Iris Spiliopoulou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iris Spiliopoulou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iris Spiliopoulou. The network helps show where Iris Spiliopoulou may publish in the future.

Co-authorship network of co-authors of Iris Spiliopoulou

This figure shows the co-authorship network connecting the top 25 collaborators of Iris Spiliopoulou. A scholar is included among the top collaborators of Iris Spiliopoulou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iris Spiliopoulou. Iris Spiliopoulou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bombelli, Cecilia, Livia Pagano, Foteini Gkartziou, et al.. (2022). Resveratrol-Loaded Glycosylated Liposomes for Targeting Bacteria. SHILAP Revista de lepidopterología. 61–61. 2 indexed citations
2.
Baig, Sharmin, Anders Rhod Larsen, Patrícia Martins-Simões, et al.. (2020). Evolution and Population Dynamics of Clonal Complex 152 Community-Associated Methicillin-Resistant Staphylococcus aureus. mSphere. 5(4). 17 indexed citations
3.
Papadimitriou‐Olivgeris, Matthaios, Fevronia Kolonitsiou, Vasileios Karamouzos, et al.. (2020). Molecular characteristics and predictors of mortality among Gram-positive bacteria isolated from bloodstream infections in critically ill patients during a 5-year period (2012–2016). European Journal of Clinical Microbiology & Infectious Diseases. 39(5). 863–869. 9 indexed citations
4.
5.
Papadimitriou‐Olivgeris, Matthaios, Anastasia Spiliopoulou, Fotini Fligou, et al.. (2017). Risk factors and predictors of mortality of candidaemia among critically ill patients: role of antifungal prophylaxis in its development and in selection of non-albicans species. Infection. 45(5). 651–657. 12 indexed citations
6.
Δρούγκα, Ελεάννα, Antigoni Foka, Christos K. Koutinas, et al.. (2016). Interspecies spread of Staphylococcus aureus clones among companion animals and human close contacts in a veterinary teaching hospital. A cross-sectional study in Greece. Preventive Veterinary Medicine. 126. 190–198. 31 indexed citations
7.
Assimakopoulos, Stelios F., D. Dimitropoulou, Anastasia Spiliopoulou, et al.. (2015). Toxoplasma gondii meningoencephalitis without cerebral MRI findings in a patient with ulcerative colitis under immunosuppressive treatment. Infection. 43(5). 589–593. 2 indexed citations
8.
Giormezis, Nikolaos, et al.. (2014). Virulence factors among Staphylococcus lugdunensis are associated with infection sites and clonal spread. European Journal of Clinical Microbiology & Infectious Diseases. 34(4). 773–778. 19 indexed citations
9.
Spiliopoulou, Iris, et al.. (2011). Linezolid-Resistant Enterococci in Greece: Epidemiological Characteristics. Chemotherapy. 57(3). 181–185. 7 indexed citations
10.
Esteban, Jaime, Diana Molina‐Manso, Iris Spiliopoulou, et al.. (2010). Biofilm development by clinical isolates ofStaphylococcusspp. from retrieved orthopedic prostheses. Acta Orthopaedica. 81(6). 674–679. 46 indexed citations
11.
Christofidou, M., Eleni Jelastopulu, Iris Spiliopoulou, et al.. (2008). EPIDEMIOLOGY OF CHRONIC HEPATITIS C VIRUS INFECTION IN HIGH RISK GROUPS. Hepatitis Monthly. 8(1). 11–16. 5 indexed citations
12.
Spiliopoulou, Iris. (2008). Clonal Evolution and Antibiotic Resistance Profile of Methicillin-Resistant Staphylococcus aureus in Greece during a Five-Year Period. 46th Annual Meeting. 1 indexed citations
13.
Spiliopoulou, Iris, et al.. (2007). Molecular Epidemiology and Antibiotic Resistance Patterns of <i>Salmonella enterica</i> from Southwestern Greece. Chemotherapy. 53(6). 392–396. 10 indexed citations
16.
Jelastopulu, Eleni, et al.. (2005). Sensitivity of the Cobas Amplicor system for detection of Mycobacterium tuberculosis in respiratory and extrapulmonary specimens. Clinical Microbiology and Infection. 11(7). 593–596. 12 indexed citations
17.
Spiliopoulou, Iris, Ilda Santos‐Sanches, Christina Bartzavali, et al.. (2003). Application of Molecular Typing Methods to Characterize Nosocomial Coagulase-Negative Staphylococci Collected in a Greek Hospital During a Three-Year Period (1998–2000). Microbial Drug Resistance. 9(3). 273–282. 13 indexed citations
19.
Kalfarentzos, F, et al.. (1996). Oral ornithine a-ketoglutarate accelerates healing of thesmall intestine and reduces bacterial translocation after abdominal radiation. Clinical Nutrition. 15(1). 29–33. 13 indexed citations
20.
Spiliopoulou, Iris, et al.. (1995). Beta-thalassaemia and the prevalence of HCV viraemia.. PubMed. 27(1). 15–22. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026